Med Page Today
MAY 30, 2024
(MedPage Today) -- Preeclampsia raised the risk of young-onset dementia, a prospective study of nearly 2 million women in France showed. Compared with pregnancies without hypertensive disorders, preeclampsia more than doubled the risk of dementia.
DAIC
MAY 30, 2024
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System. PPMC, part of the University of Pennsylvania Health System, renowned for advanced clinical research, innovation, and compassionate patient care, stands at the forefront as the
Med Page Today
MAY 30, 2024
(MedPage Today) -- In this exclusive video interview, Jeremy Faust, MD, editor-in-chief of MedPage Today, and Jerome Adams, MD, MPH, discuss Adams' recent emergency department (ED) bill and the many factors that can lead to a patient's "financial.
DAIC
MAY 30, 2024
milla1cf Thu, 05/30/2024 - 10:22 May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the Kosmos ultrasound system, developed by EchoNous , brings to cardiac evaluations for chemotherapy patients. This AI-powered device enables even non-expert ultrasound users, such as junior oncologists and nurses, to accurately and swiftly assess left ventricular ejection fraction (LVEF), a crucial indicator of heart health and a critical measure
HCPLive
MAY 30, 2024
The new psychedelic CPT codes, effective January 1, 2024, could impact MDMA if approved. The FDA's Psychopharmacologic Drugs Advisory Committee will discuss MDMA on June 4.
DAIC
MAY 30, 2024
Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan. Image courtesy: Elixir Medical christine.book Thu, 05/30/2024 - 10:36 May 30, 2024 — Elixir Medical , a developer of technologies to treat cardiovascular and peripheral disease, announced during the recent Euro PCR 2
Science Daily - Heart Disease
MAY 30, 2024
A mouse study of heart failure with preserved ejection fraction (HFpEF) found male-female differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
MAY 30, 2024
milla1cf Thu, 05/30/2024 - 10:14 May 30, 2024 — B iotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system.
Dr. Smith's ECG Blog
MAY 30, 2024
Written by Magnus Nossen, with some edits by Smith This ECG was transmitted electronically by EMS for evaluation. The patient is a 70 something female with chest discomfort and dyspnea. How would you interpret the ST changes seen in this ECG? Will you accept this patient for emergent coronary angiogram based on the ECG changes? Does the ECG represent STEMI-negative OMI findings?
American College of Cardiology
MAY 30, 2024
Is vessel-level coronary atherosclerotic plaque activity using coronary 18F-sodium fluoride positron emission tomography (PET) associated with patient vessel-level myocardial infarction (MI)?
Society of Thoracic Surgeons - Congenital
MAY 30, 2024
The STS Workshop on Robotic Cardiac Surgery provided surgeons from across the country two days of hands-on team training for mitral valve repair, coronary bypass, and other surgery procedures in a cardiac robotics simulation environment.
Cardiovascular Diabetology
MAY 30, 2024
Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis.
HCPLive
MAY 30, 2024
Patients with AATD-associated lung disease on augmentation therapy participating in a health management program experienced negligible changes in self-perceived health status.
Becker's Hospital Review - Cardiology
MAY 30, 2024
Four New York-based Northwell Health hospitals received top ratings for cardiothoracic surgery specialties from the Society of Thoracic Surgeons.
HCPLive
MAY 30, 2024
At week 54, the clinical remission rate among patients receiving originator infliximab was 92.5% compared with 100% in the biosimilar CT-P13 group.
Becker's Hospital Review - Cardiology
MAY 30, 2024
Richard Heuser, MD, an internationally recognized cardiologist, inventor and educator, died May 23, according to an announcement on his website.
HCPLive
MAY 30, 2024
Anjali Tiku Owens, MD, explores the role of cardiac myosin inhibitors in the treatment strategies for patients with obstructive hypertrophic cardiomyopathy (oHCM), in accordance with the latest European Society of Cardiology (ESC) Guidelines released in 2023.
Circulation
MAY 30, 2024
Circulation, Ahead of Print. The psychological safety of health care workers is an important but often overlooked aspect of the rising rates of burnout and workforce shortages. In addition, mental health conditions are prevalent among health care workers, but the associated stigma is a significant barrier to accessing adequate care. More efforts are therefore needed to foster health care work environments that are safe and supportive of self-care.
HCPLive
MAY 30, 2024
Anjali Tiku Owens, MD, examines mavacamten, the pioneering cardio myosin inhibitor (CMI) approved for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), which is exclusively accessible through the restricted Risk Evaluation and Mitigation Strategy (REMS) program; the KOL delves into the objectives of this program and how it strives to enhance medication safety and optimize patient outcomes.
HeartRhythm
MAY 30, 2024
As one of the first protagonists of the method of direct-current (DC) catheter ablation (also called “fulguration”) of cardiac arrhythmias, I was interested in the historical article on the “First Ablation” recently published by Dr Melvin Scheinman (1). Dr Scheinman and his collaborators played a tremendous role in the development and wide international acceptance of this method as he already detailed it in his first reflections on the topic in 2003 (2).
HCPLive
MAY 30, 2024
Announced on May 29, 2024, data from the MDD3001 trial indicate use of seltorexant was associated with meaningful improvements in depressive symptoms and sleep disturbances.
HeartRhythm
MAY 30, 2024
The comments by Robert Frank regarding my recent description of the first planned ablation1 are much appreciated. Foremost, because it allows me to dispense with any feelings of ill will towards 2 people (Drs. Frank and Fontaine) who I greatly admire. I did not mention your case report in my original description since I was not aware of your report.
HCPLive
MAY 30, 2024
Blocking IL-33 production with statins may be an effective preventive strategy to suppress chronic inflammation and the development of certain cancers.
All About Cardiovascular System and Disorders
MAY 30, 2024
The term Temporary Permanent Pacemaker will seem to be a contradiction of terms, but it is a reality! One of the earliest reports of using temporary permanent pacemaker was in the setting of an infected cardiac implantable electronic device (CIED) in a pacemaker dependent patient. In such a patient, a temporary pacemaker wire may be required for long periods during antibiotic treatment.
HCPLive
MAY 30, 2024
The analysis of NHANES data revealed a dose-response association between weekly moderate-to-vigorous physical activity levels and hyperuricemia risk.
Journal of Cardiovascular Pharmacology
MAY 30, 2024
An abstract is unavailable. This article is available as a PDF only.
HCPLive
MAY 30, 2024
Robert Rosenson, MD, discusses the results of the ARCHES-2 trial and how it informs the potential of ANGPTL3 inhibition as well as RNAi therapies.
American College of Cardiology
MAY 30, 2024
What are the sex-specific baseline clinical and echocardiographic characteristics at referral for degenerative mitral regurgitation (DMR) due to flail leaflets and subsequent management and outcomes?
Expert insights. Personalized for you.
140 
Let's personalize your content